More recently, we found that the diagnostic accuracy for serum BACE1 (sBACE1) activity increased from 76 to 99%, when the diagnosis of MCI (due to AD) and AD was supported by core CSF biomarkers [18]. The gene discussed is BACE1; the disease is Alzheimer disease.